NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,448 Cr | ₹1,154 Cr | ₹1,096 Cr | ₹919 Cr | ₹808 Cr |
What is the latest Total Expenditure of NEULAND LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹1,448 Cr |
| Mar2025 | ₹1,154 Cr |
| Mar2024 | ₹1,096 Cr |
| Mar2023 | ₹919 Cr |
| Mar2022 | ₹808 Cr |
How is Total Expenditure of NEULAND LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,448 Cr | 25.56 | |
| Mar2025 | ₹1,154 Cr | 5.25 | |
| Mar2024 | ₹1,096 Cr | 19.21 | |
| Mar2023 | ₹919 Cr | 13.72 | |
| Mar2022 | ₹808 Cr | - | |
Compare Total Expenditure of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,981.4 Cr | 3.5% | 15.3% | 67.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.5% |
15.3% |
67.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses